Gevo’s Production Plans Prompt ‘Relief Rally,’ Analyst Says

Gevo Inc., the U.S. biotechnology company backed by oil refiner Total SA and specialty chemicals maker Lanxess AG, rose the most in two weeks after saying it expects to begin shipments in July, on schedule, from a plant it’s completing in Minnesota.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.